Conrad Shipyard’s backlog stretches well into 2025, with orders for tugs, towboats, ferries, barges and a series of ...

The third quarter marked an important transition for Skye as a metabolic-focused company with the launch of our Phase 2 obesity clinical trial for nimacimab. We believe our truly ...